Pharma News – 23.01.2023 to 29.01.2023
Mankind Pharma invests in Actimed Therapeutics to support the latter’s development of treatment for cancer cachexia. On 23 January 2023, […]
Mankind Pharma invests in Actimed Therapeutics to support the latter’s development of treatment for cancer cachexia. On 23 January 2023, […]
On 4 February 2023, Lupin announced the recall of Clobetasol propionate cream over quality issues. As per the USFDA [1], the pharma
Lupin issues nationwide recall of Clobetasol propionate cream. Read More »
The USFDA[1] has revealed that Global Pharma Healthcare recalls all the batches of artificial tears lubricant eye drops from the
Global Pharma Healthcare recalls Artificial Tears Lubricant eye drops. Read More »
Cancer research and discovery is the process of uncovering new information about cancer and how it can be treated. This
USFDA issues OAI notice for Torrent Pharma’s Indrad facility in Gujarat.In response to this notice, Torrent Pharma has clarified that
On 23 January 2023, Mankind Pharma announced its move to invest in the UK-based clinical-stage specialty pharma company Actimed Therapeutics.
Cancer Cachexia: Mankind Pharma’s association with Actimed Therapeutics Read More »
Aculys Pharma and Four H have announced a research collaboration to explore the potential of wearable devices to improve clinical
Zydus receives USFDA’a approval for marketing its epilepsy and menopause drugs. Pharma news- On 2 December 2022, Zydus received the
GC Pharma and Tottori University have collaborated to accelerate the global development of the chaperone therapy of GM1 gangliosidosis (GM1).
pharma News July 2021: Let us know what’s happening around the globe and the Indian Pharma Industry. Three-dose ZyCoV-D vaccine